Patents Assigned to Tensha Therapeutics, Inc.
  • Treatment of conditions associated with hyperinsulinaemia
    Patent number: 10925881
    Abstract: The present invention relates to treatment of a condition associated with hyperinsulinaemia using the compounds described herein.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: February 23, 2021
    Assignee: Tensha Therapeutics, Inc.
    Inventors: Steven B. Landau, Michael H. Kagey
  • Bromodomain inhibitors
    Patent number: 10124009
    Abstract: The present invention relate to bromodomain inhibitor compounds, pharmaceutical compositions comprising the bromodomain inhibitor compounds and methods of treating a disorder responsive to fee modulation of a BET family polypeptide using the compounds and pharmaceutical compositions described.
    Type: Grant
    Filed: October 27, 2015
    Date of Patent: November 13, 2018
    Assignee: Tensha Therapeutics, Inc.
    Inventors: Steven B. Landau, Michael Kagey